3.7 Organ Transplantation Study Guide

Case Study: Claudia’s Trachea Transplant - Claudia received a replacement trachea using a pioneering technology. - The transplant involved a combination of donor cartilage and Claudia’s own cells. - The process utilized a cartilage "scaffold" onto which the recipient's cells were grown. - This technology was considered highly successful for her specific case.
Evolution of Transplantation - Early 1800s: Medical exploration into tissue transplants began with the first attempts at blood transfusions. - 1954: The first successful organ transplant, a kidney, took place. - Matching: The 1954 procedure was successful because the living donor and the recipient were identical twins.
Organizational Support: The Trillium Gift of Life Network is an organization that encourages the donation of life-saving organs and tissues.

Transplantable Organs: Currently includes the heart, liver, lung, pancreas, and intestines.
Transplantable Tissues: Includes the cornea, skin, bone, bone marrow, tendons, and blood vessels.
Detailed List (Figure 1): - Organs: Heart, lungs, liver, kidneys, pancreas, intestines. - Tissues: Corneas, heart valves, veins, skin, bone, ligaments, tendons, cartilage.
Sources of Donation: - Some organs and tissues are safe to transplant from living donors. - Other body parts are strictly harvested only from deceased donors.

Benefits to the Recipient: The primary benefit is the ability for the recipient to live a healthy, normal life.
Benefits to the Donor and Family: Donors (or families of deceased donors) gain the satisfaction and knowing that their donation saved another person’s life.
Benefits to Society: Medical researchers gain extensive new knowledge about the human body from research in this field, benefiting society as a whole.
Risks and Complications: - Rejection: This is the most significant risk associated with transplant surgery. The recipient’s immune system identifies the new organ as foreign and attempts to destroy it. - Minimizing Rejection: Rejection is minimized by using tissues that are genetically similar to the recipient. - Immunosuppression: Most patients must take drugs to prevent the immune system from rejecting the tissue. This results in the body’s reduced ability to fight off infections.
Statistics and the "Long Wait": - The demand for organs far exceeds the available supply, resulting in long waiting lists. - In Ontario, there is an average of approximately $1700$ people on waiting lists for organ transplants. - Up to $30\,\%$ of individuals on waiting lists die before a suitable organ can be located.

Definitions: Living donor organs are provided by a living person who voluntarily chooses to donate a kidney, a lobe of a lung, or a part of their liver.
Specific Living Donor Procedures: - Lung Transplantation: This requires two separate donors. Each donor provides one lobe of a lung, and both lobes are then transplanted into the recipient (Figure 2). - Kidney Donation: Requires only one donor. Humans can lead a normal life with only one functioning kidney. - Liver Transplantation: Doctors remove one lobe of the donor’s liver for the recipient. - Regeneration Property: The liver is unique in its ability to regenerate. Over time, both the transplanted lobe in the recipient and the remaining portion in the donor will grow to form complete, functional liver tissue.
Genetic Factors: Most living donors are relatives of the recipient. This relationship increases the likelihood of a genetic match and minimizes the risk of rejection.
Advantages: Apart from matching, the primary advantage is the significantly reduced waiting time.
Risks to Living Donors: - Loss of the "backup system" provided by duplicate organs. - Standard risks associated with any major surgical procedure.

Prevalence: The majority of organs used for transplantation are sourced from deceased individuals.
Consent Process: - Ideally, an individual makes the decision to donate while alive by signing a donor card and informing their family members (Figure 3). - Family members can provide consent after a person's death even if no donor card was signed.
Organ Selection and Assessment: - Upon the death of a potential donor, organs are checked to ensure they are healthy and undamaged. - Medical professionals use specific criteria to find the most appropriate recipient, including: - Blood and tissue types. - Age of the donor and recipient. - Location of the donor and recipient. - Duration of time the recipient has been on the waiting list.

Definition: Xenotransplantation is the process of transplanting body parts or living tissues from one species to another (e.g., from an animal to a human).
Current Applications: Pig heart valves are already used to replace damaged human heart valves. However, these are chemically treated to kill the cells and are no longer considered living tissue.
Major Hurdles: The rejection of living tissue remains the primary obstacle in xenotransplantation.
Ethical and Social Controversies: - Animal Welfare: Opposition to killing animals specifically to harvest their organs. - Psychological Concerns: Some individuals object to the idea of having animal parts in their bodies. - Public Health Risks: Questions regarding the potential risks to the general public and how the process should be regulated. - Canadian Context: While no studies involving human xenotransplantation are currently active in Canada, the Canadian Public Health Association has evaluated the issue.
Key Ethical Questions Raised: - Is the procedure truly needed? - What are the acceptable risks to the public? - What are the specific human and animal issues that must be considered? - How should regulations and controls be implemented? - Are there viable alternatives to xenotransplantation?